Signal Genetics (SGNL) Reports Q1 Loss of Per Share $0.26

Signal Genetics (NASDAQ: SGNL) reported Q1 EPS of ($0.26), versus ($0.45) reported last year. Revenue for the quarter came in at $808 million, versus $645 million reported last year.

For earnings history and earnings-related data on Signal Genetics (SGNL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c